Brello Health Membership Fees Explained: What Medication Costs Extra?

Last reviewed: September 18, 2026 Last updated: September 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health charges no separate membership fee. The program is medication-inclusive: compounded semaglutide costs $399 upfront for a three-month supply, and compounded tirzepatide costs $499 upfront for an 11-week supply. Both prices are prepaid and cover the clinician visit, prescription, medication, and shipping. Semaglutide requires a three-month minimum commitment; renewal terms after the initial period were not confirmed in the captured evidence. Tirzepatide rebills automatically every 11 weeks at $499 and may be canceled anytime. Over 12 months, Brello's prepaid structure projects to approximately $133 per month for semaglutide (if the $399 rate repeats) and $197 per month for tirzepatide—lower than many month-to-month alternatives but requiring upfront payment every cycle.

At-a-glance: Brello Health vs PlexusDx

Sources: Brello Health primary pages (brellohealth.com), PlexusDx product pages. All prices verified at capture; confirm current rates at checkout.

Breaking down the membership-fee structure

Brello Health charges no separate membership fee for either its semaglutide or tirzepatide programs. The upfront payment covers every component: the initial clinician consultation, the prescription, the compounded medication itself, and shipping. This all-inclusive model means you pay one figure per cycle and receive everything needed to start or continue treatment.

For compounded semaglutide, that figure is $399 for a three-month supply (captured September 4, 2026, from brellohealth.com). The program requires a three-month minimum commitment. Renewal terms after the initial three months were not confirmed in the evidence we gathered, so if you plan to continue beyond the first cycle, confirm the rebill process and pricing directly with Brello Health before enrolling.

For compounded tirzepatide, the cost is $499 for an 11-week supply (captured September 4, 2026, from tirzepatidewoo.brellohealth.com). Tirzepatide rebills automatically every 11 weeks at the same $499 rate, and you may cancel anytime—no long-term contract beyond the initial order. Eleven weeks is approximately 2.5 months, not a full quarter, so while Brello's marketing materials sometimes reference a per-month equivalent of about $166, that figure divides $499 by three for simplicity rather than reflecting the actual 11-week cycle.

What medication costs "extra"? The short answer is nothing—medication is included in the $399 or $499 upfront price. There are no add-on fees for the drug, no separate pharmacy charge, and no membership renewal invoice. The question in practice becomes whether you prefer to pay several hundred dollars at once for a multi-month supply or spread the cost across monthly billing cycles.

Normalized 12-month cost comparison

Prepaid cycles and monthly subscriptions are difficult to compare at face value. The table below projects each program's cost over 12 months, assuming continued treatment at the documented rates. All figures are our calculation from the verified per-cycle prices.

*Assumes four three-month cycles at $399 each; renewal pricing after the initial three-month minimum is not confirmed in the evidence.
**Calculated as 4.73 eleven-week cycles (52 weeks ÷ 11 ≈ 4.73) × $499 ≈ $2,359. Tirzepatide rebills every 11 weeks per verified terms.

Arithmetic detail (tirzepatide): One year contains 52 weeks. At an 11-week cycle, you complete 52 ÷ 11 ≈ 4.73 cycles in 12 months. Multiplying 4.73 × $499 yields approximately $2,359 over the year, or $2,359 ÷ 12 ≈ $197 per month effective cost. This is higher than the $166 figure sometimes quoted by dividing $499 by three months, because 11 weeks is shorter than three calendar months and you pay more cycles per year.

Semaglutide projection caveat: The $1,596 twelve-month figure assumes the $399 rate repeats every three months for a total of four cycles. Brello's evidence states a three-month minimum but does not document auto-rebill terms or confirm that subsequent cycles remain $399. If you plan long-term semaglutide treatment, verify the renewal price and billing cadence before committing.

Decision factors: prepaid savings vs monthly flexibility

Where Brello Health's prepaid model wins

• Lower effective monthly cost for both medications when projected over 12 months, if you complete multiple cycles at the documented rates.
• No separate membership fee—every component is bundled into the upfront payment.
• Transparent cycle pricing—you know the exact dollar amount due each period (11 weeks for tirzepatide, three months for semaglutide).
• Flexible cancellation for tirzepatide—cancel anytime, though you've already prepaid the current 11-week cycle.

Where Brello Health's model has gaps or trade-offs

• Upfront cash requirement—$399 or $499 due at once, which may be a larger budget commitment than a monthly charge.
• Semaglutide renewal terms unclear—the three-month minimum is documented, but whether the program auto-renews, requires manual re-enrollment, or changes price after the first cycle is not confirmed in the evidence.
• Tirzepatide cycle length creates billing frequency—11 weeks means you pay roughly every 2.5 months, not on a calendar-quarter schedule, which can complicate budgeting if you prefer monthly predictability.
• Review evidence limited—a Trustpilot profile exists for Brello Health (trustpilot.com/review/brellohealth.com), but our research pass did not capture specific rating data or negative themes. We recommend checking the profile and recent Reddit threads (search "Brello Health reddit") to see current user reports before enrolling.

Where PlexusDx's month-to-month model wins

• No upfront lump sum—charges spread evenly across 12 monthly bills ($189 for semaglutide, $289 for tirzepatide), which may be easier to budget and reduces initial commitment.
• Cancel anytime without forfeiting a prepaid period—you pay only for the current month, and stopping treatment means no future charges.
• Same price at every dose—titration from starter to maintenance incurs no price increase, simplifying cost planning through the full protocol.
• Established Trustpilot rating—PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Choose Brello Health if…

You are comfortable paying $399 or $499 upfront each cycle and want the lowest effective monthly cost over a year of treatment. Brello's prepaid structure delivers a lower per-month rate than month-to-month programs—approximately $56 per month less than PlexusDx for semaglutide and $92 per month less for tirzepatide, by our 12-month calculation. The model works best if you have confidence in multi-month commitment, prefer fewer billing events per year, and value simplicity: one payment, one shipment, no separate membership renewals. For tirzepatide specifically, the documented auto-rebill every 11 weeks and anytime cancellation add flexibility within the prepaid framework. For semaglutide, confirm renewal terms directly with Brello before enrolling if you plan to continue beyond the initial three months.

Choose PlexusDx if…

You prefer spreading cost evenly across 12 months, want the freedom to pause or stop without forfeiting a prepaid balance, or find a $399–$499 upfront payment difficult to budget. PlexusDx's month-to-month pricing—$189 for semaglutide injection, $289 for tirzepatide injection—carries no minimum commitment and no prepay requirement. You pay the same flat rate whether you are titrating up or holding at maintenance dose, and you may cancel at any point with only the current month's charge at stake. The program includes the clinician visit, prescription, compounded medication, and shipping in every monthly fee, exactly as Brello does, but structures payment as a predictable recurring charge rather than a lump sum every 11 weeks or quarter. For individuals who value monthly cash-flow predictability or who are uncertain how long they will remain on treatment, the month-to-month model reduces financial risk even though the effective annual cost is higher.

Methodology and freshness

We captured Brello Health's pricing, billing terms, and program structure from the company's primary product pages (brellohealth.com and tirzepatidewoo.brellohealth.com) on September 4, 2026. PlexusDx pricing was verified from product pages between July 17 and July 23, 2026. The 12-month cost projections and effective monthly rates shown in this article are our calculation, derived by multiplying the verified per-cycle price by the number of cycles in 52 weeks (4 for semaglutide's three-month cycle, 4.73 for tirzepatide's 11-week cycle) and dividing the annual total by 12 months. Brello's semaglutide renewal terms—whether the program auto-rebills at $399 after the initial three-month minimum or requires re-enrollment—were flagged as unconfirmed in our research pass; readers planning long-term treatment should verify rebill mechanics and pricing directly with Brello Health. Review data: we confirmed that Trustpilot and Reddit profiles exist for Brello Health but did not capture specific rating figures or negative themes in the indexed research pass; readers should consult those platforms directly. PlexusDx's 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher) was captured September 9, 2026, from trustpilot.com/review/plexusdx.com. Pricing may change; confirm all figures at checkout before purchasing.

Frequently Asked Questions

Does Brello Health charge a membership fee separate from medication cost?

No. Brello Health charges no separate membership fee. The $399 semaglutide or $499 tirzepatide upfront payment is all-inclusive: it covers the clinician visit, prescription, compounded medication, and shipping for the entire cycle.

How often do I pay for Brello Health's tirzepatide program?

Tirzepatide rebills every 11 weeks at $499. Eleven weeks is approximately 2.5 months, so you will be charged roughly 4.7 times per year. The program may be canceled anytime, though you cannot recover the current prepaid cycle once billed.

Can I cancel Brello Health after the first semaglutide cycle?

Brello's semaglutide program requires a three-month minimum commitment, meaning you pay $399 upfront for the full three months. Whether the subscription auto-renews, requires manual re-enrollment, or changes price after the initial cycle was not confirmed in the evidence. Contact Brello directly to clarify cancellation and renewal terms before enrolling.

Why is PlexusDx's semaglutide more expensive over 12 months than Brello's?

PlexusDx charges $189 per month with no prepay, totaling $2,268 over 12 months. Brello's prepaid model—$399 every three months—projects to $1,596 annually if that rate repeats, saving approximately $672. The trade-off is upfront cash and less billing flexibility.

Are Brello Health's medications FDA-approved?

No. Brello Health dispenses compounded semaglutide and tirzepatide, which are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for each patient.

Sources

• Brello Health semaglutide program page, brellohealth.com/home1 (accessed September 4, 2026)
• Brello Health tirzepatide program page, tirzepatidewoo.brellohealth.com (accessed September 4, 2026)
• PlexusDx semaglutide injection product page, plexusdx.com/products/semaglutide-injection (accessed July 17–23, 2026)
• PlexusDx tirzepatide injection product page, plexusdx.com/products/tirzepatide-injection (accessed July 17–23, 2026)
• Trustpilot profile for PlexusDx, trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• Trustpilot profile for Brello Health, trustpilot.com/review/brellohealth.com (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.